ENL - Enaleni Pharmaceuticals Limited - Trading up
ENL
ENL
ENL - Enaleni Pharmaceuticals Limited - Trading update
Enaleni Pharmaceuticals Limited
(Incorporated in the Republic of South Africa)
(Registration number 2002/018027/06)
(JSE code: ENL & ISIN: ZAE000067740)
("Enaleni")
Trading update
In terms of the JSE Limited Listings Requirements, companies are required to
publish a trading statement as soon as they are reasonably certain that the
financial results for the current reporting period will be more than 20%
different than that of the previous corresponding period.
Shareholders are now advised that it is expected that both earnings per share
and headline earnings per share will be 110% to 120% higher than those of the
prior comparative period.
The above information has not been reviewed or reported on by the company`s
auditors and the company`s results for the year ended 31 December 2006 are
expected to be published on or about 19 March 2007.
27 February 2007
Sponsor
Nedbank Capital
Date: 27/02/2007 16:11:01 Produced by the JSE SENS Department.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
